K. G. Warren, I. Catz, K. W. Wucherpfennig: Tolerance induction to myelin basic protein by intravenous synthetic peptides containing epitope P85 VVHFFKNIVTP96 in chronic progressive multiple sclerosis. In: J Neurol Sci. 152, 1997, S. 31–38. PMID 9395124
K. G. Warren, I. Catz, L. Z. Ferenczi, M. J. Krantz: Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5 years of follow-up treatment. In: Eur J Neurol. 13, 2006, S. 887–895. PMID 16879301
